• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Coronavirus Disease 2019 (COVID-19): A Systematic Review of 133 Children Presented with Kawasaki-like Multisystem Inflammatory Syndro

tetano

Editor, Senior Moderator
J Med Virol


. 2021 May 10.
doi: 10.1002/jmv.27067. Online ahead of print.
Coronavirus Disease 2019 (COVID-19): A Systematic Review of 133 Children Presented with Kawasaki-like Multisystem Inflammatory Syndrome


Pedram Keshavarz[SUP] 1 2 [/SUP], Fereshteh Yazdanpanah[SUP] 3 [/SUP], Sara Azhdari[SUP] 4 [/SUP], Hadiseh Kavandi[SUP] 5 [/SUP], Parisa Nikeghbal[SUP] 2 [/SUP], Amir Bazyar[SUP] 2 [/SUP], Faranak Rafiee[SUP] 2 [/SUP], Seyed Faraz Nejati[SUP] 2 [/SUP], Faranak Ebrahimian Sadabad[SUP] 2 [/SUP], Nima Rezaei[SUP] 6 7 8 [/SUP]



Affiliations

Abstract

Background: Kawasaki-like disease (KLD) and multisystem inflammatory syndrome in children (MIS-C) are considered as challenges for pediatric patients under the age of 18 infected with coronavirus disease 2019 (COVID-19).
Methods: A systematic search was performed on July 2, 2020, and updated on December 1, 2020, to identify studies on KLD/MIS-C associated with COVID-19. The databases of Scopus, PubMed, Web of Science, Embase, and Scholar were searched. The hospitalized children with a presentation of Kawasaki disease (KD), KLD, MIS-C, or inflammatory shock syndromes were included.
Results: A total number of 133 children in 45 studies were reviewed. Seventy-four (55.6%) cases had been admitted to pediatric intensive care units (PICUs). As well, 49 (36.8%) patients had required respiratory supports, of whom 31 (23.3%) cases had been required mechanical ventilation/intubation, 18 (13.5%) cases had required other oxygen therapies. In total, 79 (59.4 %) cases had been discharged from hospitals, 3 (2.2%) had been readmitted, 9 (6.7%) had been hospitalized at the time of the study, and 9 (6.7%) patients had expired due to the severe heart failure, shock, brain infarction. The outcomes had not been reported in other patients.
Conclusion: Approximately two-thirds of the children with KLD associated with COVID-19 had been admitted to PICUs, around one-fourth of them had required mechanical ventilation/intubation, and even some of them had been required readmissions. Therefore, physicians are strongly recommended to monitor children presented with the characteristics of KD during the pandemic as they can be the dominant manifestations in children with COVID-19. This article is protected by copyright. All rights reserved.

Keywords: COVID-19; Children; Kawasaki Disease; Multisystem Inflammatory Syndrome; Pediatrics.
 
Back
Top Bottom